Walleye Capital
CRL icon

Walleye Capital’s Charles River Laboratories CRL Stock Holding History

Walleye Capital’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,000
Closed -$345K – 4796
2026
Q1 		$345K Buy
+2,000
New +$371K ﹤0.01% 2956
2025
Q4 		– Sell
-1,000
Closed -$156K – 4645
2025
Q3 		$156K Sell
1,000
-1,200
-55% -$191K ﹤0.01% 3467
2025
Q2 		$334K Sell
2,200
-300
-12% -$40K ﹤0.01% 2972
2025
Q1 		$376K Sell
2,500
-1,800
-42% -$302K ﹤0.01% 2783
2024
Q4 		$794K Buy
4,300
+2,400
+126% +$462K ﹤0.01% 2585
2024
Q3 		$374K Buy
1,900
+1,000
+111% +$208K ﹤0.01% 3561
2024
Q2 		$186K Sell
900
-2,000
-69% -$453K ﹤0.01% 4356
2024
Q1 		$786K Sell
2,900
-2,000
-41% -$478K ﹤0.01% 2811
2023
Q4 		$1.16M Sell
4,900
-4,300
-47% -$846K ﹤0.01% 2227
2023
Q3 		$1.8M Sell
9,200
-7,200
-44% -$1.48M ﹤0.01% 1816
2023
Q2 		$3.45M Buy
16,400
+7,000
+74% +$1.39M 0.01% 963
2023
Q1 		$1.9M Buy
+9,400
New +$2.13M 0.03% 757
2022
Q4 		– Sell
-300
Closed -$59K – 3256
2022
Q3 		$59K Buy
+300
New +$64.8K ﹤0.01% 2555
2020
Q1 		– Sell
-3,600
Closed -$550K – 1055
2019
Q4 		$550K Sell
3,600
-7,400
-67% -$1.02M 0.04% 635
2019
Q3 		$1.46M Sell
11,000
-7,400
-40% -$992K 0.09% 314
2019
Q2 		$2.61M Buy
18,400
+7,800
+74% +$1.06M 0.29% 54
2019
Q1 		$1.54M Buy
+10,600
New +$1.39M 0.25% 76

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Walleye Capital's CRL Position: Q2 2026 in Review

Walleye Capital sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 1,932 shares — an estimated $333K sold.

Walleye Capital first reported a position in CRL in Q1 2019 and held it in 16 quarters. The position peaked at $50.1M in Q4 2025. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Walleye Capital reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 1,932 Charles River Laboratories shares in Q2 2026, an estimated $333K.
  • Walleye Capital first reported a position in Charles River Laboratories in Q1 2019 and held it in 16 quarters.
  • Walleye Capital's Charles River Laboratories position peaked at $50.1M in Q4 2025.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.